Ascentage Pharma Group International (AAPG) Equity Average: 2023-2024
- Ascentage Pharma Group International's Equity Average fell 29.58% to $23.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $23.7 million, marking a year-over-year decrease of 29.58%. This contributed to the annual value of $23.8 million for FY2024, which is 32.89% down from last year.
- Ascentage Pharma Group International's Equity Average amounted to $23.7 million in Q4 2024, which was down 29.58% from $33.6 million recorded in Q4 2023.
- Ascentage Pharma Group International's 5-year Equity Average high stood at $33.6 million for Q4 2023, and its period low was $23.7 million during Q4 2024.
- In the last 2 years, Ascentage Pharma Group International's Equity Average had a median value of $28.7 million in 2023 and averaged $28.7 million.
- Data for Ascentage Pharma Group International's Equity Average shows a maximum YoY fell of 29.58% (in 2024) over the last 5 years.
- Over the past 2 years, Ascentage Pharma Group International's Equity Average (Quarterly) stood at $33.6 million in 2023, then decreased by 29.58% to $23.7 million in 2024.
